Xeris' G-Pen similar to standard kit in Phase III hypoglycemia

Xeris Pharmaceuticals Inc. (NASDAQ:XERS) said its G-Pen glucagon injection rescue pen had comparable efficacy to

Read the full 158 word article

User Sign In